Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Carcinoma, Non-Small-Cell Lung × ganitumab × Clear all

Phase

Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Immunoblastic Lymphadenopathy 1 Desmoplastic Small Round Cell Tumor 1 Carcinoma, Non-Small-Cell Lung 1 Burkitt Lymphoma 1

Interventions

pembrolizumab 106 Carboplatin 96 Pemetrexed 70 Paclitaxel 67 Cisplatin 67 Erlotinib Hydrochloride 50 Docetaxel 50 Nivolumab 48 Gemcitabine 44 Radiotherapy 42 Bevacizumab 30 osimertinib 26 Cetuximab 26 atezolizumab 23 Cyclophosphamide 23 durvalumab 21 130-nm albumin-bound paclitaxel 18 Oxaliplatin 16 Taxes 15 Radiosurgery 15 Magnetic Resonance Spectroscopy 15 Gefitinib 15 Fluorouracil 15 fludarabine 14 Vinorelbine 14 Everolimus 13 Vorinostat 12 Specimen Handling 11 Leucovorin 11 Drug Therapy 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01061788 2019-08-28

RAP

Duke University

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡